NCT04597359 2026-03-02
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT07137819 2025-08-22
EXACT-1
Aresus Pharma GmbH
Phase 3 Recruiting
NCT04055142 2024-07-10
TreatAIN
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Completed
NCT02622568 2017-09-08
Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT02029352 2016-05-18
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer
Maastricht University Medical Center
Phase 2/3 Completed
NCT01490008 2012-04-19
Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers
MediGene
Phase 1 Completed
NCT01082302 2010-09-08
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
MediGene
Phase 4 Completed